CRM -8.7% Quarterly Results: Buying Opportunity?
Back to News
us-stocksinvestingmarket-analysiscrmnyse

CRM -8.7% Quarterly Results: Buying Opportunity?

CRM stock plummets 8.7% after disappointing quarterly results. US investors weigh options as the stock trades at $153.21. Is it time to buy or cut losses?

3 min readApril 24, 2026

CRM stock has plummeted 8.7% to $153.21 after the company released its quarterly results, which fell short of analyst expectations. The NYSE-listed stock has been under pressure, with 8.7% decline in a single day, sparking concerns among US retail investors. The company's revenue and earnings per share (EPS) missed the consensus estimates, leading to a sharp selloff in the stock.

What's Happening Right Now

The CRM stock is currently trading at $153.21, down 8.7% from its previous close. The stock has been volatile, with a 52-week range of $114.22 to $224.86. The NASDAQ composite index is also under pressure, trading 0.5% lower at 13,431.18. Other US-listed stocks in the technology sector, such as MSFT and GOOGL, are also trading lower, down 0.2% and 0.5% respectively.

Why It Matters for US Investors

The CRM quarterly results have significant implications for US investors, particularly those with a long-term perspective. The company's missed expectations have raised concerns about its growth prospects and ability to execute on its strategy. US retail investors should consider the fundamental analysis of the company, including its revenue growth, profit margins, and competitive position in the market. The technical analysis also suggests that the stock is oversold, with a Relative Strength Index (RSI) of 30.12, which may indicate a potential buying opportunity.

What Analysts Are Saying

Analysts at Goldman Sachs have downgraded the CRM stock to neutral from buy, citing the company's missed expectations and increasing competition in the market. However, analysts at Morgan Stanley have maintained their overweight rating, citing the company's strong long-term growth prospects and attractive valuation. The consensus estimate for the stock is a price target of $180.50, which represents a 17.6% upside from the current price.

Key Takeaways

  • The CRM stock has plummeted 8.7% after disappointing quarterly results.
  • The company's revenue and EPS missed consensus estimates, raising concerns about its growth prospects.
  • US retail investors should consider the fundamental and technical analysis of the stock before making a decision.

Frequently Asked Questions

Is CRM a good buy after the quarterly results?

The answer depends on the individual investor's risk tolerance and investment goals. While the stock is oversold and has a strong long-term growth prospects, the company's missed expectations and increasing competition in the market are concerns that need to be considered.

What is the outlook for the CRM stock in the short-term?

The short-term outlook for the CRM stock is uncertain, with the potential for further volatility and downside risk. However, the technical analysis suggests that the stock is oversold, which may indicate a potential buying opportunity.

Should I cut losses and sell my CRM stock?

The decision to sell the CRM stock depends on the individual investor's investment goals and risk tolerance. If the investor has a long-term perspective and believes in the company's growth prospects, it may be worth holding onto the stock. However, if the investor is concerned about the company's missed expectations and increasing competition, it may be worth considering selling the stock and cutting losses.